Skip to main content
Equibles

Susan L. Drexler

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Susan L. Drexler

Earlier roles on record: CFO at Rein Therapeutics, Inc. (RNTX) until March 25, 2024. Rein Therapeutics, Inc. reported in an 8-K filed March 29, 2024 that Susan L. Drexler resigned as Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective March 25, 2024.

“On March 25, 2024, Susan L. Drexler, Interim Chief Financial Officer, principal financial officer and principal accounting officer of Aileron Therapeutics, Inc. (the "Company"), notified the Company of her resignation, effective as of March 25, 2024.”
Rein Therapeutics, Inc. Form 8-K, filed March 29, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.